Solid Organ Transplant Clinical Trial
Official title:
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
In solid organ transplant (SOT) the receipt of influenza vaccine in an influenza season is associated with decreased disease severity as demonstrated by the presence of pneumonia and ICU admissions. Different strategies have been assessed to optimize vaccine efficacy and immunogenicity of the influenza vaccine in the solid organ transplant recipient (SOTR). The primary objective of the study is to evaluate the immunogenicity of 2 doses of the high dose influenza vaccine utilizing neutralizing antibody assays. A control group receiving 1 HD influenza vaccine will be included.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03950414 -
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
|
Phase 1 | |
Completed |
NCT05124509 -
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
|
||
Completed |
NCT05121142 -
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
|
Phase 1 | |
Completed |
NCT01058239 -
Bortezomib Plus Rituximab for EBV+ PTLD
|
Phase 2 | |
Withdrawn |
NCT03327987 -
Early Flu Shots in SOT
|
||
Completed |
NCT04253548 -
iPeer2Peer Pediatric Thoracic Transplantation
|
N/A | |
Recruiting |
NCT05164016 -
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
|
||
Withdrawn |
NCT02464306 -
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
|
Phase 4 | |
Completed |
NCT02165423 -
Discharge to Home and Chronic Illness Care Pilot
|
N/A | |
Completed |
NCT00907023 -
Transition From Hospital to Home in Solid Organ Transplant (SOT)
|
N/A | |
Recruiting |
NCT04613206 -
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
|
Phase 2 | |
Recruiting |
NCT05550298 -
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
|
||
Completed |
NCT00518778 -
Fusariosis in Solid-Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT04331275 -
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
|
Phase 2 | |
Recruiting |
NCT05968807 -
iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT03482739 -
Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients
|
Phase 3 | |
Not yet recruiting |
NCT04721288 -
REmote moBile Outpatient mOnitoring in Transplant 2.0
|
N/A | |
Completed |
NCT04844489 -
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
|
N/A | |
Active, not recruiting |
NCT03360682 -
Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients
|
Phase 4 |